2025/06/23 更新

お知らせ

 

写真a

フナツ ジユン
舩津 淳
FUNATSU JUN
所属
九州大学病院 眼科 助教
医学部 医学科(併任)
職名
助教
連絡先
メールアドレス

論文

  • Comparison of Microperimetry and Static Perimetry for Evaluating Macular Function and Progression in Retinitis Pigmentosa

    Fukushima, M; Tao, Y; Shimokawa, S; Zhao, HY; Shimokawa, S; Funatsu, J; Hisai, T; Okita, A; Fujiwara, K; Hisatomi, T; Takeda, A; Ikeda, Y; Sonoda, KH; Murakami, Y

    OPHTHALMOLOGY SCIENCE   4 ( 6 )   100582   2024年12月   ISSN:2666-9145

     詳細を見る

    記述言語:英語   出版者・発行元:Ophthalmology Science  

    Purpose: To compare the usefulness of microperimetry and static automated perimetry in patients with retinitis pigmentosa (RP), using macular anatomical metrics as a reference. Design: Prospective observational study. Participants: Forty-eight eyes of 48 patients with RP in Kyushu University Hospital who underwent microperimetry-3 (MP-3) and Humphrey Field Analyzer (HFA) 10-2 testing ≥3 times during ≥2 years were included. Methods: Macular anatomy (ellipsoid zone [EZ] length) was assessed by OCT, and macular function was assessed by MP-3 (mean retinal sensitivity at radii 2°, 4°, and 8°) and HFA10-2 program (mean retinal sensitivity at radii 2°, 4°, and 8°). Correlations between functional and anatomical parameters were analyzed cross sectionally at baseline and longitudinally by comparing the rate of progression. Main Outcome Measures: Correlation coefficients between anatomical and functional metrics. Results: The mean age at baseline was 50.1 ± 12.3 years, and the mean follow-up period was 2.8 ± 0.7 years. At baseline, EZ length was significantly correlated with MP-3 mean retinal sensitivity at radii 2°, 4°, and 8° (Spearman's ρ = 0.65, 0.84, 0.89; all P < 0.005) and HFA10-2 mean retinal sensitivity at radii 2°, 4°, and 8° (Spearman's ρ = 0.61, 0.73, 0.78; all P < 0.005). Longitudinal analysis showed that the slope of EZ length (−88.92 μm/year) was significantly correlated with the slope of MP-3 retinal sensitivity at 8° radius (−0.62 decibels [dB]/year; Spearman's ρ = 0.31, P=0.03) and the slope of HFA retinal sensitivity at 8° radius (−0.60 dB/year; Spearman's ρ = 0.43, P < 0.005). Conclusions: Both MP-3 and HFA values were cross sectionally well-correlated with EZ length in patients with patients; however, these associations became weaker in the longitudinal analysis. This highlights the need for researchers to explore additional or more sensitive parameters to better monitor RP progression. Financial Disclosure(s): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

    DOI: 10.1016/j.xops.2024.100582

    Web of Science

    Scopus

    PubMed

  • Intraocular kinetics of pathological ATP after photoreceptor damage in rhegmatogenous retinal detachment

    Tachibana, T; Notomi, S; Funatsu, J; Fujiwara, K; Nakatake, S; Murakami, Y; Nakao, S; Kanamoto, T; Ikeda, Y; Ishibashi, T; Sonoda, KH; Hisatomi, T

    JAPANESE JOURNAL OF OPHTHALMOLOGY   68 ( 5 )   500 - 510   2024年9月   ISSN:0021-5155 eISSN:1613-2246

     詳細を見る

    記述言語:英語   出版者・発行元:Japanese Journal of Ophthalmology  

    Purpose: Extracellular Adenosine triphosphate (ATP) released by dying cells may cause a secondary cell death in neighboring cells in retinal degeneration. We investigated intraocular ATP kinetics to gain mechanical insights into the pathology in rhegmatogenous retinal detachment (RRD). Study design: Retrospective clinical study. Methods: Vitreous or subretinal fluids (SRF) were obtained from patients with RRD (n=75), macular hole (MH; n=20), and epiretinal membrane (ERM; n=35) during vitrectomy. ATP levels in those samples were measured by luciferase assay. Results: Mean ATP levels in the vitreous from RRD patients were significantly higher compared to those from MH and ERM patients (2.3 and 0.3 nM, respectively. P<0.01). Mean ATP levels in the SRF from RRD (11.7 nM) were higher than those in the vitreous from RRD (P<0.01). Mean ATP levels in the vitreous with short durations (1–8 days) of RRD were higher compared to those with long durations (>8 days) (3.2 and 1.4 nM, respectively. P<0.05). Similarly, ATP in SRF with short durations were higher than those with long durations (23.8 and 3.6 nM, respectively. P<0.05). Furthermore, the concentrations of ectonucleoside triphosphate diphosphohydrolase-1 (ENTPD1), a major ATP degradative enzyme, in the vitreous from RRD were higher than those from MH/ERM (1.2 and 0.2 ng/ml, respectively. P<0.01). ENTPD1 expression was localized in the cytoplasm of CD11b-positive infiltrating cells in the vitreous and retinal cells. Conclusion: ATP increased in the vitreous and SRF in RRD and decreased over time with an upregulation of ENTPD1. The kinetics indicate the pathological mechanism of the excessive extracellular ATP after RRD.

    DOI: 10.1007/s10384-024-01087-x

    Web of Science

    Scopus

    PubMed

  • Intraocular kinetics of pathological ATP after photoreceptor damage in rhegmatogenous retinal detachment(タイトル和訳中)

    Tachibana Takashi, Notomi Shoji, Funatsu Jun, Fujiwara Kohta, Nakatake Shunji, Murakami Yusuke, Nakao Shintaro, Kanamoto Takashi, Ikeda Yasuhiro, Ishibashi Tatsuro, Sonoda Koh-Hei, Hisatomi Toshio

    Japanese Journal of Ophthalmology   68 ( 5 )   500 - 510   2024年9月   ISSN:0021-5155

     詳細を見る

    記述言語:英語   出版者・発行元:シュプリンガー・ジャパン(株)  

    裂孔原性網膜剥離(RRD)にみられる眼内アデノシン三リン酸(ATP)の動態を検討した。RRD患者75例、黄斑円孔(MH)患者20例および網膜上膜(ERM)患者35例から硝子体切除中に硝子体液または網膜下液(SRF)を採取してATP濃度を測定した。RRD群の硝子体中ATP値は2.28±4.27nMであり、MH/ERM群(0.30±0.65nM)より有意に高く、SRF中ATP値は11.7±25.1nMと硝子体中濃度と比較して有意に高値を示していた。RRD群を罹病期間1~8日の32例と8日超の32例に分けると、罹病期間短期群の方が硝子体中・SRF中ATP値は高くなっていた。また、硝子体中ATPの分解能はRRD群の方がMH/ERM群より有意に高く、RRD群のアデノシン二リン酸(ADP)値はMH/ERM群より高かったことから、過剰なATPに対して酵素的分解が生じていると考えられた。さらに、RRD群でエクトヌクレオチダーゼとしてのENTPD1の濃度を測定したところ、罹病期間短期群と長期群との間に有意差はみられず、ENTPD1はRRDの発症直後に発現を呈して長期間にわたり維持されると考えられ、ENTPD1は硝子体細胞と網膜細胞の細胞質内に局在していた。ATPはRRD患者の硝子体とSRFにおいて高発現を呈し、ENTPD1のアップレギュレーションに伴って経時的に減少していた。

  • Comparison of Microperimetry and Static Perimetry for Evaluating Macular Function and Disease Progression in Retinitis Pigmentosa

    Fukushima, M; Murakami, Y; Tao, Y; Shimokawa, S; Zhao, H; Shimokawa, S; Funatsu, J; Fujiwara, K; Takeda, A; Ikeda, Y; Sonoda, KH

    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE   64 ( 8 )   2023年6月   ISSN:0146-0404 eISSN:1552-5783

     詳細を見る

  • MyD88 but not Card9 signaling mediates neuroprotective microglial activation in a mouse model of retinitis pigmentosa

    Shimokawa, S; Murakami, Y; Funatsu, J; Fukushima, M; Ikeda, Y; Sonoda, KH

    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE   63 ( 7 )   2022年6月   ISSN:0146-0404 eISSN:1552-5783

     詳細を見る

  • Circulating inflammatory monocytes oppose microglia and contribute to cone cell death in retinitis pigmentosa

    秋山 雅人, 納富 昭司, 武田 篤信

    PNAS NEXUS   1 ( 1 )   1 - 14   2022年3月   eISSN:27526542

     詳細を見る

    記述言語:英語   出版者・発行元:Oxford University Press  

    Retinitis pigmentosa (RP) is an intractable inherited disease that primarily affects the rods through gene mutations followed by secondary cone degeneration. This cone-related dysfunction can lead to impairment of daily life activities, and ultimately blindness in patients with RP. Paradoxically, microglial neuroinflammation contributes to both protection against and progression of RP, but it is unclear which population(s)— tissue-resident microglia and/or peripheral monocyte-derived macrophages (mϕ)— are implicated in the progression of the disease. Here, we show that circulating blood inflammatory monocytes (IMo) are key effector cells that mediate cone cell death in RP. Attenuation of IMo and peripherally engrafted mϕ by Ccl2 deficiency or immune modulation via intravenous nanoparticle treatment suppressed cone cell death in rd10 mice, an animal model of RP. In contrast, the depletion of resident microglia by a colony-stimulating factor 1 receptor inhibitor exacerbated cone cell death in the same model. In human patients with RP, IMo was increased and correlated with disease progression. These results suggest that peripheral IMo is a potential target to delay cone cell death and prevent blindness in RP.

    DOI: 10.1093/pnasnexus/pgac003

    Web of Science

    Scopus

    PubMed

    CiNii Research

  • Recurrence rate of cystoid macular edema with topical dorzolamide treatment and its risk factors in retinitis pigmentosa

    Shimokawa S., Murakami Y., Fujiwara K., Funatsu J., Nakatake S., Koyanagi Y., Akiyama M., Yoshida N., Takeda A., Ikeda Y., Sonoda K.H.

    Retina   42 ( 1 )   168 - 173   2022年1月   ISSN:0275004X

     詳細を見る

    記述言語:英語   出版者・発行元:Retina  

    Purpose: To investigate the rate of the recurrence of cystoid macular edema (CME) secondary to retinitis pigmentosa (RP) after the initiation of topical dorzolamide and the recurrence risk factors. Methods: We retrospectively analyzed the data of RP patients at Kyushu University Hospital. We included patients who showed a treatment response to 1.0% topical dorzolamide. The day of treatment initiation was set as the baseline. Topical dorzolamide treatment was continued during the follow-up. The recurrence of CME (defined as a .20% increase in central subfield thickness compared to previous visit, or a central subfield thickness value that exceed baseline value) was evaluated at each follow-up visit. Risk factors for RP-CME recurrence were analyzed by Cox proportional hazards modeling. A Kaplan–Meier survival analysis was used to evaluate the time to recurrent RP-CME. Results: Forty RP-CME patients showed a treatment response to topical dorzolamide. During the mean 3.9-year follow-up, 14 patients exhibited recurrence; its rate was 15.6%, 34.7%, and 48.7% at 1, 3, and 5 years, respectively. A high baseline central subfield thickness was significantly associated with recurrent (hazard ratio 1.11, 95% CI: 1.05–1.18, P = 0.0004). Conclusion: The recurrence rate of RP-CME increased with time. A high baseline central subfield thickness value was a risk factor for recurrence.

    DOI: 10.1097/IAE.0000000000003286

    Scopus

    PubMed

  • RECURRENCE RATE OF CYSTOID MACULAR EDEMA WITH TOPICAL DORZOLAMIDE TREATMENT AND ITS RISK FACTORS IN RETINITIS PIGMENTOSA

    Shimokawa, S; Murakami, Y; Fujiwara, K; Funatsu, J; Nakatake, S; Koyanagi, Y; Akiyama, M; Yoshida, N; Takeda, A; Ikeda, Y; Sonoda, KH

    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES   42 ( 1 )   168 - 173   2022年1月   ISSN:0275-004X eISSN:1539-2864

     詳細を見る

▼全件表示

講演・口頭発表等

MISC